Up to 52% of COPD patients, including those with mild disease, struggle to inhale from a DPI,10¶ which is associated with poor outcomes11#
GOLD 2023 RECOMMENDATIONS
Match the inhaler with each patient’s inhalation ability1
pMDIs and, to a lesser extent, SMIs require coordination and for patients to make a slow, deep inhalation1
DPIs are only appropriate if the patient can make a forceful, deep inhalation1
SPIOLTO® RESPIMAT® -
actively delivered through a soft mist5 that can make it easy for your patients to inhale8,9
Higher lung deposition than specific pMDIs and DPIs12
Improves lung function, irrespective of inhalation effort13||
Suitable for a range of patients with COPD12,13